Additional file 1 of The landscape of immune checkpoint inhibitor therapy in advanced lung cancer

Additional file 1: Fig. S1 Funnel plot of the effect size for each trial. Fig. S2 Drug targets analysis for NSCLC. Fig. S3 Therapeutic scheme analysis for SCLC. Table S1 Search strategies. Table S2 The methodological quality of included RCTs. Table S3 Differences in OS benefits of Immunotherapy in NSCLC and SCLC by subgroups